Author | Julie N. Graff, MD | OncLive

Author | Julie N. Graff, MD

Articles

Dr. Graff on Combination Regimens With Checkpoint Inhibitors in mCRPC

April 30, 2020

Video

Julie N. Graff, MD, discusses potential combination regimens with checkpoint inhibitors in metastatic castration-resistant prostate cancer.

Dr. Graff on the KEYNOTE-641 Trial in mCRPC

March 23, 2020

Video

Julie N. Graff, MD, associate professor of medicine, Oregon Health & Science University Knight Cancer Institute, discusses the phase III KEYNOTE-641 trial in metastatic castration-resistant prostate cancer (mCRPC).

Dr. Graff on the Safety of Checkpoint Inhibition in mCRPC

March 18, 2020

Video

Julie N. Graff, MD, discusses the safety profile of pembrolizumab plus enzalutamide in patients with metastatic castration-resistant prostate cancer.

Dr. Graff on Results of the KEYNOTE-199 Trial in mCRPC

February 27, 2020

Video

Julie N. Graff, MD, discusses the results of the phase II KEYNOTE-199 trial in metastatic castration-resistant prostate cancer.

x